Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 36
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Mutagenesis ; 20(5): 311-5, 2005 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-15985443

RESUMEN

Hexavalent chromium is an established carcinogenic agent, which is not directly reactive with DNA. Its genotoxicity involves a reduction step, producing reactive oxygen species and radicals, and also lower valence forms which form stable complexes with intracellular macromolecules. The trivalent form of chromium may directly react with the genetic material and has also been shown to generate oxidative damage in vitro. To further evaluate the importance of in vivo oxidative DNA damage in the toxicity of each valence form, we conducted a comparative study on hexavalent and trivalent chromium-exposed workers (manual metal arc stainless steel welders and leather tanning workers), focusing on the total oxidative status by quantifying the level of lipoperoxidation products in urine. Thiol antioxidants are important in response to oxidative stress, and therefore, the concentration of glutathione and cysteine in peripheral blood lymphocytes was also determined. Chromium exposure was evaluated by quantifying total chromium in plasma and urine. Both groups had a significant increase in lipid peroxidation products expressed as malondialdehyde (MDA) in urine (tanners 1.42 +/- 0.61 micromol/g creatinine, welders 1.67 +/- 1.13 micromol/g creatinine versus controls 0.81 +/- 0.26 micromol/g creatinine, P < 0.005 in both cases) but only welders had a significant decrease in glutathione concentration in lymphocytes. There was a positive correlation between chromium in plasma and urinary MDA in welders, but not in tanners. This work is part of a larger study of which major results have been published previously including cytogenetics and DNA-protein cross-links in workers exposed to the two different forms of chromium. These results are compared with the results of oxidative damage from this study.


Asunto(s)
Carcinógenos/toxicidad , Cromo/toxicidad , Cisteína/análisis , Glutatión/análisis , Peroxidación de Lípido , Exposición Profesional , Antioxidantes/análisis , Cromo/sangre , Cromo/orina , Humanos , Linfocitos/química , Malondialdehído/orina , Estrés Oxidativo , Compuestos de Sulfhidrilo/análisis , Sustancias Reactivas al Ácido Tiobarbitúrico/análisis
2.
Bioorg Med Chem ; 11(8): 1631-8, 2003 Apr 17.
Artículo en Inglés | MEDLINE | ID: mdl-12659748

RESUMEN

Catechols from abietic acid were prepared by a short and good yielding chemical process and further evaluated for several biological activities namely, antifungal, antitumoral, antimutagenic, antiviral, antiproliferative and inhibition of nitric oxide. Their properties were compared with those of carnosic acid (6), a naturally occurring catechol with an abietane skeleton and known to possess potent antioxidant activity, as well as anticancer and antiviral properties. From all the synthetic catechols tested compound 2 showed the best activities, stronger than carnosic acid.


Asunto(s)
Abietanos/química , Catecoles/síntesis química , Catecoles/farmacología , Fenantrenos/química , Animales , Antifúngicos/síntesis química , Antifúngicos/farmacología , Antimutagênicos/síntesis química , Antimutagênicos/farmacología , Antineoplásicos/síntesis química , Antineoplásicos/farmacología , Antivirales/síntesis química , Antivirales/farmacología , Arthrodermataceae/efectos de los fármacos , Diferenciación Celular , Línea Celular , Diterpenos/farmacología , Relación Dosis-Respuesta a Droga , Humanos , Activación de Linfocitos/efectos de los fármacos , Ratones , Óxido Nítrico/antagonistas & inhibidores , Extractos Vegetales/farmacología , Salmonella typhimurium/efectos de los fármacos , Células Tumorales Cultivadas , Virus/efectos de los fármacos
3.
Mutagenesis ; 18(1): 19-24, 2003 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-12473731

RESUMEN

DNA-protein crosslinks (DPC) are a promising biomarker of exposure to hexavalent chromium, a known human carcinogen. Although trivalent chromium is considered to have much lower toxicity, the risk involved in chronic exposure is uncertain. DPC may be a useful tool in clarifying this risk, by signaling an exposure of body tissues to biologically active forms of chromium. DPC quantification was carried out in lymphocytes of a group of tannery workers exposed to trivalent chromium, a small group of manual metal arc stainless steel welders exposed to hexavalent chromium and a control group. This biomarker was compared with the frequency of micronuclei in cytokinesis blocked peripheral lymphocytes as a biomarker of cytogenetic lesions and total plasma and urine chromium levels as an index of exposure. The results indicate a significant increase in the formation of DPC in tannery workers compared with controls (0.88 +/- 0.19 versus 0.57 +/- 0.21%, P < 0.001, Mann-Whitney test) and an even higher level of DPC in welders (2.22 +/- 1.12%, P = 0.03). Tanners showed a significant increase in micronucleated cells compared with controls (6.35 +/- 2.94 versus 3.58 +/- 1.69 per thousand, P < 0.01), whereas in welders this increase was not significant (5.40 +/- 1.67 per thousand ). Urinary chromium was increased in both groups, with a greater increase observed in tanners compared with controls (2.63 +/- 1.62 versus 0.70 +/- 0.38 microg/g creatinine, P < 0.001) than in welders (1.90 +/- 0.37 microg/g creatinine, P < 0.005). Plasma chromium was also increased in both groups (tanners 2.43 +/- 2.11 microg/l, P < 0.001, welders 1.55 +/- 0.67 microg/l, P < 0.005 versus controls 0.41 +/- 0.11 microg/l). In summary, chronic occupational exposure to trivalent chromium can lead to a detectable increase in lymphocyte DNA damage which correlates with a significant exposure of the cells to the metal.


Asunto(s)
Cromo/efectos adversos , Reactivos de Enlaces Cruzados/efectos adversos , Daño del ADN , Contaminantes Ambientales/efectos adversos , Linfocitos/química , Exposición Profesional , Curtiembre , Adulto , Cationes , Cromo/sangre , Cromo/orina , Creatinina/sangre , ADN/efectos de los fármacos , Contaminantes Ambientales/sangre , Contaminantes Ambientales/orina , Femenino , Humanos , Linfocitos/ultraestructura , Masculino , Pruebas de Micronúcleos , Persona de Mediana Edad , Proteínas/efectos de los fármacos , Fumar/epidemiología , Soldadura
4.
Cancer Genet Cytogenet ; 123(1): 55-60, 2000 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-11120336

RESUMEN

The relationship between the presence of high frequencies of chromosomal aberrations in peripheral lymphocytes and predisposition to cancer has been suggested for some cancer diseases. In nonfamilial thyroid cancer, the few reports available are equivocal. The aim of this study was to assess the possible chromosomal instability in peripheral blood lymphocytes from 22 patients suffering from nonfamilial thyroid cancer. For this purpose, 2 classic cytogenetic assays, the chromosomal aberrations assay and cytokinesis-blocked micronucleus assay, were chosen. The frequency of chromosomal aberrations excluding gaps (%) was 1.68 +/- 1.39 (mean value +/- SD) for the patients group versus 2.20 +/- 1.87 for the control group. The frequency of binucleated lymphocytes with micronuclei ( per thousand) was 5.41 +/- 3.51 (mean value +/- SD) for the patients group versus 5.37 +/- 3.21 for the control group. The results obtained revealed no significant differences between both groups. The present study reinforces the idea that constitutional chromosomal instability in peripheral blood lymphocytes is not visible in nonfamilial thyroid carcinomas.


Asunto(s)
Aberraciones Cromosómicas , Linfocitos/metabolismo , Micronúcleos con Defecto Cromosómico/metabolismo , Neoplasias de la Tiroides/genética , Adulto , División Celular/efectos de los fármacos , Citocalasina B/farmacología , Femenino , Humanos , Linfocitos/efectos de los fármacos , Linfocitos/patología , Masculino , Micronúcleos con Defecto Cromosómico/genética , Pruebas de Micronúcleos , Persona de Mediana Edad , Índice Mitótico , Neoplasias de la Tiroides/patología , Neoplasias de la Tiroides/radioterapia
5.
Teratog Carcinog Mutagen ; 20(4): 241-9, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-10910474

RESUMEN

Instant coffee exhibits genotoxic activity upon nitrosation at acidic pH values in the Ames tester strain TA100. Using adsorption chromatography (Amberlit XAD-2) it was observed that the major fraction of molecules responsible for the genotoxic activity upon nitrosation was not retained on this resin, suggesting that the polar molecules present in instant coffee could be responsible for the genotoxicity observed upon nitrosation. Some phenolic molecules present in instant coffee (catechol, caffeic acid, and chlorogenic acid) were also genotoxic upon nitrosation under the same experimental conditions. The concentrations of nitrosatable phenolic compounds in the studied coffee were determined by HPLC and their contributions to the total genotoxicity observed were studied. The results obtained suggest that besides phenolic compounds other molecules were also involved in the genotoxicity of this beverage upon nitrosation. Teratogenesis Carcinog. Mutagen. 20:241-249, 2000.


Asunto(s)
Café/toxicidad , Mutágenos/toxicidad , Nitratos/metabolismo , Fenoles/metabolismo , Adsorción , Ácidos Cafeicos/metabolismo , Catecoles/metabolismo , Cromatografía , Cromatografía Líquida de Alta Presión , Café/metabolismo , Relación Dosis-Respuesta a Droga , Concentración de Iones de Hidrógeno , Hidroquinonas/metabolismo , Pruebas de Mutagenicidad , Mutágenos/metabolismo , Nitrosación , Pirogalol/metabolismo , Salmonella typhimurium/metabolismo
6.
Crit Rev Toxicol ; 30(3): 287-306, 2000 May.
Artículo en Inglés | MEDLINE | ID: mdl-10852498

RESUMEN

There is an increasing need for metabolic competent cell systems for the mechanistic studies of biotransformation of xenobiotics in toxicology in general and in genotoxicology in particular. These cell systems combine the heterologous expression of a particular mammalian biotransformation enzyme with a specific target/ end point by which a functional analysis of the expressed gene product in the (geno)toxicity of chemicals can be performed. cDNAs of an increasing number of mammalian biotransformation enzymes is being cloned. The construction of specific expression vectors permits their heterologous expression in laboratory bacteria, such as Escherichia coli strains. This development does not only allow biochemical and enzymatic studies of (pure) enzyme preparations but also facilitates the engineering of metabolically competent mutagenicity tester bacteria, thereby providing new tools for genotoxicity testing and for studying of the roles of biotransformation in chemical carcinogenesis. In this review, we describe an update as well as an evaluation of enzymes expressed in mutagenicity tester bacteria. Four types of biotransformation enzymes are now expressed in these bacteria, namely, GSTs, CYPs, NATs, and STs. The expression of these enzymes in the tester bacteria and their subsequent application in mutagenicity assays demonstrates that heterologous expression in this type of bacteria has a number implications for the functionality of the biotransformation enzymes as well as for the functioning of the tester bacteria in mutagenicity detection. We also describe here a number of practical considerations in this regard.


Asunto(s)
Sistema Enzimático del Citocromo P-450/metabolismo , Escherichia coli/enzimología , Mutágenos/metabolismo , Salmonella typhimurium/enzimología , Transferasas/metabolismo , Xenobióticos/metabolismo , Animales , Biotransformación , ADN Complementario/metabolismo , Escherichia coli/efectos de los fármacos , Microsomas/efectos de los fármacos , Microsomas/enzimología , Pruebas de Mutagenicidad , Mutágenos/toxicidad , Ratas , Salmonella typhimurium/efectos de los fármacos , Xenobióticos/toxicidad
7.
Mutagenesis ; 15(3): 229-34, 2000 May.
Artículo en Inglés | MEDLINE | ID: mdl-10792015

RESUMEN

Patulin is a mycotoxin produced by several species of Penicillium, Aspergillus and BYSSOCHLAMYS: Patulin is a common contaminant of ripe apples used for the production of apple juice concentrates and is also present in other fruits, vegetables and food products. Patulin has been reported to have mutagenic, carcinogenic and teratogenic properties. Nevertheless, these properties are still a matter of debate. In this report, we further investigated the genotoxicity of patulin in mammalian cells by two different approaches. Firstly, we evaluated the induction of micronuclei in cytokinesis-blocked human lymphocytes. This approach is important because available data concerning the genetic toxicity of patulin in human cells is sparse. Secondly, we chose an established model for patulin genotoxicity, i.e. the chromosomal aberration assay in V79 Chinese hamster cells, to clarify whether concomitant exposure to ascorbic acid with the mycotoxin modulates or not the clastogenicity of patulin. The results unequivocally show induction of DNA-damaged cells by patulin as assessed by both cytogenetic assays. In addition, an almost complete abolition of patulin (0.8 microM) clastogenicity was observed in the presence of 80 microM ascorbic acid (P < 0.05), showing that although a genetic risk is present, ascorbic acid could somehow partially modulate this problem.


Asunto(s)
Antimutagênicos/farmacología , Ácido Ascórbico/farmacología , Aberraciones Cromosómicas , Linfocitos/efectos de los fármacos , Pruebas de Micronúcleos , Mutágenos/toxicidad , Patulina/toxicidad , Animales , División Celular/efectos de los fármacos , Línea Celular , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Cricetinae , Cricetulus , Humanos , Linfocitos/citología , Micotoxinas/toxicidad
8.
Chem Biol Interact ; 124(1): 29-51, 2000 Jan 03.
Artículo en Inglés | MEDLINE | ID: mdl-10658900

RESUMEN

Flavonls are natural compounds present in edible plants and possess several biological activities that can be useful in drug design. Conversely some of these compounds have been shown to be genotoxic to prokaryotic and eukaryotic cells. In this study we tried to establish the chemical features responsible for the genotoxicity of flavonols and to study the conditions that can modulate their genotoxicity namely pH, the presence of antioxidants and metabolism. We assessed the induction of revertants in Salmonella typhimurium TA98 and the induction of Chromosomal aberrations in V79 cells by eight different flavonols and one catechin in the presence and in the absence of metabolizing systems. We have also studied the generation of hydroxyl radical by these flavonoids using the deoxyribose degradation assay. The results obtained in this study suggest that flavonols having a free hydroxyl group at position 3 of the C ring, a free hydroxyl group at position 7 of the A ring and a B ring with a catechol or pyrogallol structure, or a structure that after metabolic activation is transformed into a catechol or a pyrogallol, are flavonols whose genotoxicity in eukaryotic cells depends on their autooxidation. These flavonols can autooxidize when the pH value is slightly alkaline, such as in the intestine, and therefore can induce genotoxicity in humans. Given the above mentioned considerations it is necessary to clarify the mechanisms and the conditions that mediate the biological effects of flavonols before considering them as therapeutical agents.


Asunto(s)
Flavonoides/toxicidad , Mutágenos/toxicidad , Animales , Bovinos , Línea Celular , Cricetinae , Cricetulus , Desoxirribosa/metabolismo , Diseño de Fármacos , Flavonoides/farmacocinética , Radical Hidroxilo/metabolismo , Hígado/enzimología , Hígado/metabolismo , Masculino , Pruebas de Mutagenicidad , Mutágenos/farmacocinética , Ratas , Ratas Wistar , Especies Reactivas de Oxígeno/metabolismo
9.
Mutagenesis ; 15(1): 69-75, 2000 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-10640533

RESUMEN

This study aimed to assess two end-points of DNA damage, namely chromosomal aberrations and micronuclei in peripheral lymphocytes, and their possible relationship with oxidative stress (which may be related to DNA damage and repair) in thyroid cancer patients receiving therapeutic doses of (131)I. Nineteen patients receiving 2590 MBq (70 mCi) were studied. Chromosomal aberrations were scored using standard cytogenetic methods and micronuclei scored in cytokinesis-blocked lymphocytes. Oxidative stress was assessed by determining thiobarbituric acid-reactive substances in blood, total plasma antioxidant status and serum uric acid levels. All parameters were assessed before treatment and 1 and 6 months after (131)I administration. The frequency of micronucleated cells per 1000 binucleated cells scored (mean +/- SEM) increased significantly from 5.21 +/- 0.80 to 9.68 +/- 1.22 1 month after treatment (P < 0.01) and to 8.42 +/- 1.28 6 months after treatment (P < 0.05). The frequency of cells with chromosomal aberrations, excluding gaps, per 100 cells, increased significantly from 1.68 +/- 0.41 to 3.47 +/- 0. 55 1 month after treatment (P < 0.01) and to 4.05 +/- 0.46 6 months after treatment (P < 0.01). Oxidative stress parameters showed slight modifications over the time period studied, but the differences were not significant except for a decrease in thiobarbituric acid-reactive products 6 months after therapy (P < 0. 05) and in serum uric acid concentration 1 and 6 months after therapy (P < 0.01). This report demonstrates slight but significant and persistent DNA damage in (131)I-treated patients as assessed by cytogenetic assays. There was no clear correlation between the cytogenetic findings and oxidative stress parameters studied.


Asunto(s)
Aberraciones Cromosómicas , Radioisótopos de Yodo/efectos adversos , Estrés Oxidativo , Neoplasias de la Tiroides/tratamiento farmacológico , Adulto , Anciano , Femenino , Humanos , Radioisótopos de Yodo/uso terapéutico , Linfocitos/patología , Linfocitos/ultraestructura , Masculino , Micronúcleos con Defecto Cromosómico/ultraestructura , Persona de Mediana Edad , Sustancias Reactivas al Ácido Tiobarbitúrico , Neoplasias de la Tiroides/sangre , Neoplasias de la Tiroides/patología , Ácido Úrico/metabolismo
10.
Mutat Res ; 442(1): 43-51, 1999 Jun 07.
Artículo en Inglés | MEDLINE | ID: mdl-10366772

RESUMEN

Instant coffee exhibits direct genotoxic activity in the tester strains TA 98, 100, 102, 104 and YG 1024. In the Ames tester strain TA 100, the presence of S9 mix, S100 mix, S9 mix without cofactors led to a significant decrease of the genotoxicity observed. The decrease observed in the presence of S9 mix seems to be highly correlated with the catalase content of S9 mix. The genotoxicity of instant coffee detected in strain TA 100 was dependent on the pH, with higher genotoxic effects at pH values above neutrality. Also, dependent on the pH was the ability of some phenolic molecules present in coffee promoting the degradation of deoxyribose in the presence of Fe3+/EDTA. These results suggest that apart from other molecules present in instant coffee responsible for their genotoxicity in several short term assays, phenolic molecules could also be implicated in the genotoxicity of coffee, via reactive oxygen species arising from its auto-oxidation.


Asunto(s)
Café/efectos adversos , Mutágenos/farmacología , Fenoles/farmacología , Salmonella typhimurium/efectos de los fármacos , Animales , Catalasa/metabolismo , Catalasa/farmacología , Café/química , Microsomas Hepáticos/metabolismo , Pruebas de Mutagenicidad , Mutágenos/farmacocinética , Fenoles/farmacocinética , Ratas , Superóxido Dismutasa/metabolismo , Superóxido Dismutasa/farmacología
11.
Mutat Res ; 441(1): 73-83, 1999 Apr 26.
Artículo en Inglés | MEDLINE | ID: mdl-10224324

RESUMEN

We report here on the genetic engineering of four new Escherichia coli tester bacteria, coexpressing human CYP1A1, CYP2A6, CYP3A4 or CYP3A5 with human NADPH cytochrome P450 reductase (RED) by a biplasmid coexpression system, recently developed to express human CYP1A2 in the tester strain MTC. The four new strains were compared for CYP- and RED-expression levels and CYP activities with the formerly developed CYP1A2 expressing strain. CYP1A2 and CYP2A6 were expressed at the highest, CYP1A1 at the lowest and CYP3A4 and CYP3A5 at intermediate expression levels. Membranes of all five tester bacteria demonstrated similar RED-expression levels, except for the two CYP3A-containing bacteria which demonstrated slightly increased RED-levels. CYP-activities were determined as ethoxyresorufin deethylase (CYP1A1 and CYP1A2), coumarin 7-hydroxylase (CYP2A6) and erythromycin N-demethylase (CYP3A4 and CYP3A5) activities. Reaction rates were comparable with those obtained previously for these CYP-enzymes, except for CYP3A5 which demonstrated a lower activity. Benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene demonstrated mutagenicity in the CYP1A1 expressing strain with mutagenic activities, respectively, approximately 10-fold and 100-fold higher as compared with those obtained with the use of rat liver S9 fraction. Aflatoxin B1 demonstrated a significant mutagenicity with all CYP expressing strains, albeit lower as compared to those obtained with the use of rat liver S9. CYP1A2 was approximately 3-fold more effective in generating a mutagenic response of AFB1 as compared to CYP3A4. CYP3A5 and CYP3A4 demonstrated comparable capacities in AFB1 bioactivation which was equal as found for CYP1A1. It is concluded that these four new strains contain stable CYP- and RED-expression, significant CYP-activities and demonstrated significant bioactivation activities with several diagnostic carcinogens.


Asunto(s)
9,10-Dimetil-1,2-benzantraceno/farmacología , Hidrocarburo de Aril Hidroxilasas , Benzo(a)pireno/farmacología , Citocromo P-450 CYP1A2/metabolismo , Sistema Enzimático del Citocromo P-450/metabolismo , Escherichia coli/genética , Pruebas de Mutagenicidad/métodos , NADPH-Ferrihemoproteína Reductasa/metabolismo , Animales , Clonación Molecular , Citocromo P-450 CYP1A1/genética , Citocromo P-450 CYP1A1/metabolismo , Citocromo P-450 CYP1A2/genética , Citocromo P-450 CYP2A6 , Citocromo P-450 CYP3A , Sistema Enzimático del Citocromo P-450/genética , Escherichia coli/enzimología , Humanos , Cinética , Oxigenasas de Función Mixta/genética , Oxigenasas de Función Mixta/metabolismo , Mutágenos/farmacología , NADPH-Ferrihemoproteína Reductasa/genética , Ratas , Proteínas Recombinantes/metabolismo
12.
Mutat Res ; 439(2): 287-300, 1999 Feb 19.
Artículo en Inglés | MEDLINE | ID: mdl-10023085

RESUMEN

Currently three different methods have been taken to develop new mutagenicity tester strains containing human cytochrome P450s (CYPs). Each of these use a single expression vector. In this paper we describe a fourth approach, i.e., the coexpression of a CYP and its electron-transfer flavoprotein, NADPH CYP reductase (RED), encoded by two different expression vectors. The Escherichia coli mutagenicity tester strain BMX100 has been expanded to a strain, MTC which stably expresses human RED. This new tester strain permits the biplasmid coexpression of human CYP1A2 and RED (MTC1A2). This novel strain can be used for the determination of the mutagenicity of chemicals known to be procarcinogens and metabolized by CYP1A2. The mutagenicity tester strain MTC1A2 was compared with: (i) BMX100 using the post-mitochondrial rat liver fraction (S9); (ii) BMX100 with expressing CYP1A2 alone (iii) or with expressing CYP1A2 fused to rat RED or (iv) with expressing CYP1A2, bicistronically coexpressed with rat RED. The biplasmid RED/CYP coexpression system generated a strain with the highest methoxy- and ethoxy-resorufin dealkylase activities and the highest mutagenic activities for the procarcinogens 2-aminoanthracene (2AA), aflatoxin B1 (AFB1) and 2-amino-3-methylimidazo(4,5-f)quinoline (IQ). Furthermore, the metabolism of 2AA and IQ was detected more efficiently using the MTC1A2 strain than with the BMX100 strain plus the standard rodent liver S9 metabolic system.


Asunto(s)
Sistema Enzimático del Citocromo P-450/metabolismo , Escherichia coli/genética , NADPH-Ferrihemoproteína Reductasa/genética , Animales , Western Blotting , Escherichia coli/enzimología , Vectores Genéticos , Humanos , Pruebas de Mutagenicidad , Ratas
13.
Mutagenesis ; 13(3): 263-9, 1998 May.
Artículo en Inglés | MEDLINE | ID: mdl-9643585

RESUMEN

In this study we describe the development of strain BMX100, a new Escherichia coli K12 tester strain, derived from MX100, a strain which was constructed for detection of mutagens and for mechanistic studies of chemical carcinogens. We demonstrate here that strain BMX100 can be used for stable expression of human CYP1A2 or human CYP1A2 fused to rat liver NADPH cytochrome P450 reductase. Mutagenicity of precarcinogens known to be bioactivated by CYP1A2, namely 2-aminoanthracene (2-AA), aflatoxin B1 (AFB1) and 2-amino-3-methylimidazo[4,5-f]quinoline (IQ), could be detected. The mutagenic activity of 2-AA using BMX100 expressing CYP1A2 alone and in combination with rat CYP reductase was respectively 10 and 20 times higher than in BMX100 with the standard metabolic activation system, rat liver S9 fraction. Furthermore, the mutagenicity of 2-AA could be nullified by alpha-naphthoflavone, a known inhibitor of CYP1A2. IQ responded equally in BMX100 expressing the CYP1A2-reductase fusion protein as compared with usage of rat liver S9 fraction. Rat liver S9 fraction was much more potent in generating a mutagenic response to AFB1 in BMX100 than in the strain expressing human CYP1A2 alone or CYP1A2 fused to rat reductase. The results described in this study demonstrate that this new E.coli strain can function as a human CYP1A2-competent prokaryotic mutagenicity test system and they seem to characterize BMX100 as a strain of interest for studies to identify individual human CYPs involved in bioactivation and bioinactivation reactions of putative genotoxins.


Asunto(s)
Carcinógenos/toxicidad , Citocromo P-450 CYP1A2/biosíntesis , Citocromo P-450 CYP1A2/genética , Escherichia coli/genética , 4-Nitroquinolina-1-Óxido/toxicidad , Aflatoxina B1/toxicidad , Animales , Antracenos/toxicidad , Benzo(a)pireno/toxicidad , Biotransformación/genética , Citocromo P-450 CYP1A2/metabolismo , Escherichia coli/efectos de los fármacos , Regulación Bacteriana de la Expresión Génica/efectos de los fármacos , Humanos , Pruebas de Mutagenicidad , Quinolinas/toxicidad , Ratas , Proteínas Recombinantes de Fusión/biosíntesis
14.
Mutat Res ; 393(3): 247-57, 1997 Oct 24.
Artículo en Inglés | MEDLINE | ID: mdl-9393617

RESUMEN

The mutagenicity of flavonols seems to depend on the number and position of hydroxyl groups in the B ring. Galangin is a flavonol that does not have any hydroxyl group in the B ring and has been suggested to be a substrate of cytochromes P450 which, through the hydroxylation of the B ring, could metabolise it to more genotoxic products. The present study was undertaken to test this hypothesis. Using high performance liquid chromatography we show that glangin is sequentially transformed to kaempferol and then to quercetin by a mechanism dependent on cytochrome P450 reactions. The metabolites of galangin are responsible for its mutagenicity in Salmonella typhimurium reversion assay and for the induction of chromosomal aberrations in V79 cells.


Asunto(s)
Sistema Enzimático del Citocromo P-450/metabolismo , Flavonoides/metabolismo , Microsomas Hepáticos/metabolismo , Mutágenos/metabolismo , Animales , Biotransformación , Cromatografía Líquida de Alta Presión/métodos , Aberraciones Cromosómicas , Cricetinae , Flavonoides/toxicidad , Masculino , Mutágenos/toxicidad , Ratas , Ratas Wistar , Salmonella typhimurium/metabolismo
15.
Mutagenesis ; 12(5): 383-90, 1997 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-9379919

RESUMEN

Kaempferol is a flavonoid widely distributed in edible plants and has been shown to be genotoxic to V79 cells in the absence of external metabolizing systems. The presence of an external metabolizing system, such as rat liver homogenates (S9 mix), leads to an increase in its genotoxicity, which is attributed to its biotransformation to the more genotoxic flavonoid quercetin, via the cytochrome P450 (CYP) mono-oxygenase system. In the present work we investigated the mechanisms of the genotoxicity of kaempferol further. Special attention has been given to the role of CYP in the genotoxicity of this flavonoid. We studied the induction of mutations in Salmonella typhimurium TA98 in the presence and in the absence of S9 mix and the induction of chromosomal aberrations (CAs) and micronuclei (MN) by kaempferol in V79 cells in the presence and in the absence of S9 mix. To evaluate the role of different CYP in the biotransformation of kaempferol we studied the induction of CAs and MN in V79 cells genetically engineered for the expression of rat CYP 1A1, 1A2 and 2B1. In addition we performed CYP inhibition studies using the above-mentioned indicators and high performance liquid chromatography (HPLC) analysis. The results obtained in this work suggest that rat CYP 1A1 is, among the cytochromes studied, the one that plays the major role in the transformation of kaempferol into quercetin. The relevance of these findings to the human situation is discussed.


Asunto(s)
Aberraciones Cromosómicas , Citocromo P-450 CYP1A1/metabolismo , Flavonoides , Quempferoles , Mutágenos , Quercetina/análogos & derivados , Quercetina/metabolismo , Animales , Biotransformación , Línea Celular , Cromatografía Líquida de Alta Presión , Cricetinae , Cricetulus , Citocromo P-450 CYP1A2/metabolismo , Citocromo P-450 CYP2B1/metabolismo , Humanos , Microsomas Hepáticos/metabolismo , Pruebas de Mutagenicidad , Quercetina/farmacocinética , Quercetina/toxicidad , Ratas , Proteínas Recombinantes/metabolismo , Salmonella typhimurium/efectos de los fármacos , Transfección
16.
Mutagenesis ; 12(4): 245-54, 1997 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-9237769

RESUMEN

MX100 is an Escherichia coli K12 genotoxicity tester strain, especially developed for mechanistic studies of chemical mutagens and carcinogens. For the study of the role of specific enzymes in the bioactivation and bioinactivation of carcinogens, it is necessary to characterize MX100 as far as its metabolic bio(in)activation capacities are concerned. In this study such a characterization is performed in two types of cell-free lysates, one derived from stationary phase cells, grown in rich medium (SR-lysates) and one from exponentially growing cells (log phase), cultured in minimal medium (LM-lysates). Six Phase I enzyme activities of aromatic NADPH hydroxylase, NADH hydroxylase, flavin-containing monooxygenase (FMO), nitroreductase, DT-diaphorase and NADPH ferredoxin:oxidoreductase were determined. Activities of six Phase II enzymes glutathione S-transferases (GSTs), N-aryl acetyltransferase (NAT), arylamine sulphotransferase, UDP-glucuronyltransferase and epoxide hydratase and of the Phase III enzyme cysteine conjugate beta-lyase were subsequently assessed. In addition, five antioxidant enzymes: superoxide dismutase (SOD), catalase, glutathione (GSH)-reductase, GSH-peroxidase and alkyl hydroperoxide reductase; as well as concentrations of glutathione (GSH) and its disulphide (GSSG), were measured. The activity parameters of all enzymes were compared with those obtained in similar lysates of the Salmonella strain TA100 and in rat liver preparations. The results indicate that MX100 as well as TA100 contain relatively low oxidative but high reductase Phase I activities. Both strains demonstrated low activities for the Phase II conjugation enzymes except for GSTs. In MX100, relatively high activities were detected for all antioxidative enzymes, activities which were lower in TA100. Significant differences in activities were observed between the SR-lysates derived from stationary phase/rich medium and LM-lysates from log phase/minimal medium cells for nitroreductase, GST, SOD, catalase, NADPH ferredoxin:oxidoreductase as well as in GSH content. In general, we described for the first time a metabolic characterization of the E.coli tester strain MX100 and the Salmonella typhimurium strain TA100 and discussed the results in terms of its significance for carcinogen bioactivation and bioinactivation capacities.


Asunto(s)
Carcinógenos/metabolismo , Escherichia coli/enzimología , Salmonella typhimurium/enzimología , Animales , Antioxidantes/metabolismo , Biotransformación , Carcinógenos/farmacología , Catalasa/efectos de los fármacos , Catalasa/metabolismo , División Celular/efectos de los fármacos , Medios de Cultivo , Escherichia coli/efectos de los fármacos , Glutatión/análogos & derivados , Glutatión/metabolismo , Disulfuro de Glutatión , Glutatión Reductasa/efectos de los fármacos , Glutatión Reductasa/metabolismo , Hígado/efectos de los fármacos , Hígado/metabolismo , Masculino , Pruebas de Mutagenicidad , NAD(P)H Deshidrogenasa (Quinona)/efectos de los fármacos , NAD(P)H Deshidrogenasa (Quinona)/metabolismo , Ratas , Ratas Wistar , Salmonella typhimurium/efectos de los fármacos , Superóxido Dismutasa/efectos de los fármacos , Superóxido Dismutasa/metabolismo
17.
Mutagenesis ; 11(4): 327-33, 1996 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-8671756

RESUMEN

The development of a new Escherichia coli tester strain for use in metabolic and mechanistic studies of genotoxins, strain MR2101/pKR11, has recently been reported. This strain, a derivative of the E. coli K12 laboratory strain AB1157, has sensitivity towards the detection of base-substitution mutagenesis, monitored by the reversion of arginine auxotrophy [argE3, (ochre)]. Besides arginine, MK2101/pKR11 is auxotrophic for histidine (hisG4), leucine (leuB6), proline (DeltaproA) and threonine (thr-1). MX100 was developed to overcome the auxotrophy for four amino acids of MR2101/pKR11 which are non-essential for the mutagenic responsiveness of the strain. We restored the biosynthesis for these four amino acids in MR2101/pKR11, resulting in strain MX100. This strain showed an almost 2-fold increase in mutagenic activity relative to MR2101/pKR11 with a set of diagnostic mutagens (aflatoxin B1, benzo[a]pyrene, 4-nitroquinoline-1-oxide, 2,7-dimethyl-benz[a]anthracene and others) and was further characterized with other types of mutagens in which it showed sensitivity towards the detection of oxidative (H2O2t-butyl-hydroperoxide, cumene-hydroperoxide, KO2) and carbonyl mutagens (methylglyoxal, malondialdehyde). As MX100 seems to have the right characteristics of a versatile genotoxicity tester strain and due to the extensive genetic and physiological knowledge of E. coli K12 in general and AB1157 in particular, we propose that MX100 could serve as mother strain for the development of specialized tester strains, of interest in studies of metabolism and/or mechanism of action of genotoxic carcinogens.


Asunto(s)
Escherichia coli/efectos de los fármacos , Escherichia coli/genética , Pruebas de Mutagenicidad/métodos , Aminoácidos/metabolismo , Carcinógenos/toxicidad , Escherichia coli/metabolismo , Estudios de Evaluación como Asunto , Mutágenos/toxicidad
18.
Mutat Res ; 353(1-2): 151-76, 1996 Jun 12.
Artículo en Inglés | MEDLINE | ID: mdl-8692190

RESUMEN

We present here the results obtained within the framework of an EU funded project aimed to develop and validate alternative metabolic activating systems to be used in short-term mutagenicity assays, in order to reduce the use of laboratory animals for toxicology testing. The activating systems studied were established cell lines (Hep G2, CHEL), genetically engineered V79 cell lines expressing specific rat cytochromes P450, erythrocyte-derived systems, CYP-mimetic chemical systems and plant homogenates. The metabolically competent cell lines were used as indicator cells for genotoxic effects as well as for the preparation of external activating systems using other indicator cells. The following endpoints were used: micronuclei, chromosomal aberrations and sister chromatid exchanges, mutations at the hprt locus, gene mutations in bacteria (Ames test), unscheduled DNA synthesis and DNA breaks detected in the comet assay. All metabolic systems employed activated some promutagens. With some of them, promutagens belonging to many different classes of chemicals were activated to genotoxicants, including carcinogens negative in liver S9-mediated assays. In other cases, the use of the new activating systems allowed the detection of mutagens at much lower substrate concentrations than in liver S9-mediated assays. Therefore, the alternative metabolizing systems, which do not require the use of laboratory animals, have a substantial potential in in vitro toxicology, in the basic genotoxicity testing as well as in the elucidation of activation mechanisms. However, since the data basis is much smaller for the new systems than for the activating systems produced from subcellular liver preparations, the overlapping use of both systems is recommended for the present and near future. For example, liver S9 preparations may be used with some indicator systems (e.g., bacterial mutagenicity), and metabolically competent mammalian cell lines may be used with other indicator systems (e.g., a cytogenetic endpoint) in a battery of basic tests.


Asunto(s)
Pruebas de Mutagenicidad/métodos , Animales , Biotransformación , Aberraciones Cromosómicas , Cricetinae , Sistema Enzimático del Citocromo P-450/fisiología , Reparación del ADN , Eritrocitos/metabolismo , Humanos , Mutágenos/metabolismo , Ratas , Células Tumorales Cultivadas
19.
Teratog Carcinog Mutagen ; 16(5): 253-68, 1996.
Artículo en Inglés | MEDLINE | ID: mdl-9122891

RESUMEN

Myricetin is a flavonol that is widely distributed in edible plants and although it has been proved to be genotoxic in bacteria and to induce significant concentration-dependent nuclear DNA degradation concurrent with lipid peroxidation, very little is known about its mechanisms of genotoxicity. In this work we tried to evaluate the role of rat cytochromes P450 in the genotoxicity of myricetin and to study the role that radicalar species may have in its mutagenicity. The results obtained show that the genotoxicity of myricetin as assessed by the induction of chromosomal aberrations is not different in V79 cells lines genetically engineered for the expression of rat cytochromes P450 1A1, 1A2, and 2B1, compared to parental cell lines. We have also been able to show that reactive oxygen species resulting from the autooxidation of myricetin at pH values above neutrality have an important role in its mutagenicity. Therefore, under some conditions, myricetin can act as a prooxidant.


Asunto(s)
Aberraciones Cromosómicas , Daño del ADN , Flavonoides/toxicidad , Hígado/efectos de los fármacos , Animales , Células Cultivadas , Cricetinae , Cricetulus , Citocromo P-450 CYP1A1/genética , Citocromo P-450 CYP1A1/metabolismo , Citocromo P-450 CYP1A2/genética , Citocromo P-450 CYP1A2/metabolismo , Citocromo P-450 CYP2B1/genética , Citocromo P-450 CYP2B1/metabolismo , Desoxirribosa/metabolismo , Ingeniería Genética , Concentración de Iones de Hidrógeno , Hígado/citología , Hígado/enzimología , Pruebas de Mutagenicidad , Ratas , Especies Reactivas de Oxígeno/metabolismo
20.
Teratog Carcinog Mutagen ; 16(5): 275-86, 1996.
Artículo en Inglés | MEDLINE | ID: mdl-9122893

RESUMEN

The mutagenic activity of glycine upon nitrosation was studied in the Ames tester strains TA98, TA100, TA102, and TA104. The results obtained show that glycine at acidic pH values and in the presence of Cl- can react with nitrite giving rise to genotoxic compounds to the tester strains used. When these experiments were carried out in the presence of gastric juice the genotoxicity observed was associated with the Cl- concentration in the different gastric juice samples. The nature and the mechanism of genetic lesion induced by the ultimate genotoxicant arising from the nitrosation of glycine are not fully understood. Primary amines (e.g., amino acids) have been described as potential alkylating agents after nitrosation. However, in our experimental conditions these alkylating activities were not detected, suggesting that other mechanisms could be involved in the genetic lesion induced by nitrosated glycine. The influence of Cl- in the genotoxic activity of glycine and other primary amines upon nitrosation and its possible involvement in the etiology of gastric cancer are discussed.


Asunto(s)
Cloruros/farmacología , Jugo Gástrico/metabolismo , Glicina/toxicidad , Mutágenos , Salmonella typhimurium/efectos de los fármacos , Glicina/metabolismo , Humanos , Concentración de Iones de Hidrógeno , Microsomas Hepáticos/metabolismo , Nitrosación/efectos de los fármacos , Salmonella typhimurium/genética , Neoplasias Gástricas/etiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...